Chemokines in tuberculosis: The good, the bad and the ugly

Seminars in Immunology

Volumn 26, Issue 6, 2014, Pages 552-558

  Monin, Leticia ^a,b   Khader, Shabaana A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Chemokines; Lung; Mycobacterial infections

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 2;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ASYMPTOMATIC INFECTION; BONE MARROW CELL; DENDRITIC CELL; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION CONTROL; INFLAMMATION; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; LATENT TUBERCULOSIS; LUNG; LYMPHOCYTE; MICROBIOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE;

CHEMOKINES; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LATENT TUBERCULOSIS; LUNG; LYMPHOCYTES; MYCOBACTERIUM TUBERCULOSIS; MYELOID CELLS; SIGNAL TRANSDUCTION; TH1-TH2 BALANCE; TUBERCULOSIS, PULMONARY;

EID: 84920054214     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.09.004     Document Type: Review

References (82)

1. Dye C., Glaziou P., Floyd K., Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013, 34:271-286.
2. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
3. Slight S.R., Khader S.A. Chemokines shape the immune responses to tuberculosis. Cytokine Growth Factor Rev 2013, 24:105-113.
4. Flynn J.L. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 2006, 8:1179-1188.
5. Guirado E., Schlesinger L.S., Kaplan G. Macrophages in tuberculosis: friend or foe. Sem Immunopathol 2013, 35:563-583.
6. Kang D.D., Lin Y., Rangel-Moreno J., Randall T.D., Khader S.A. Profiling early lung immune responses in the mouse model of tuberculosis. PLoS ONE 2011, 6:e16161.
7. Lin Y., Zhang M., Barnes P.F. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun 1998, 66:1121-1126.
8. Wickremasinghe M.I., Thomas L.H., Friedland J.S. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. J Immunol 1999, 163:3936-3947.
9. Nouailles G., Dorhoi A., Koch M., Zerrahn J., Weiner J., Fae K.C., et al. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest 2014, 124:1268-1282.
10. Cooper A.M., Khader S.A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 2008, 226:191-204.
11. + T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 2005, 175:3268-3272.
12. Wolf A.J., Linas B., Trevejo-Nuñez G.J., Kincaid E., Tamura T., Takatsu K., et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Exp Med 2007, 179.
13. Bhatt K., Hickman S.P., Salgame P. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J Immunol 2004, 172:2748-2751.
14. -/- mice. J Immunol 2010, 184:895-901.
15. Srivastava S., Ernst J.D. Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming. Cell Host Microbe 2014, 15:741-752.
16. + inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming. eLife 2013, 2:e01086.
17. Reiley W.W., Calayag M.D., Wittmer S.T., Huntington J.L., Pearl J.E., Fountain J.J., et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A 2008, 105:10961-10966.
18. Groom J.R., Luster A.D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 2011, 89:207-215.
19. Campbell J.D., HayGlass K.T. T cell chemokine receptor expression in human Th1- and Th2-associated diseases. Arch Immunol Ther Exp 2000, 48:451-456.
20. Mehra S., Pahar B., Dutta N.K., Conerly C.N., Philippi-Falkenstein K., Alvarez X., et al. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS ONE 2010, 5:e12266.
21. Seiler P., Aichele P., Bandermann S., Hauser A.E., Lu B., Gerard N.P., et al. Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol 2003, 33:2676-2686.
22. Chakravarty S.D., Xu J., Lu B., Gerard C., Flynn J., Chan J. The chemokine receptor CXCR3 attenuates the control of chronic Mycobacterium tuberculosis infection in BALB/c mice. J Immunol 2007, 178:1723-1735.
23. Feng W.X., Flores-Villanueva P.O., Mokrousov I., Wu X.R., Xiao J., Jiao W.W., et al. CCL2-2518 (A/G) polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis 2012, 16:150-156.
24. Chu S.F., Tam C.M., Wong H.S., Kam K.M., Lau Y.L., Chiang A.K. Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun 2007, 8:475-479.
25. Sanchez-Castanon M., Baquero I.C., Sanchez-Velasco P., Farinas M.C., Ausin F., Leyva-Cobian F., et al. Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain. Int J Tuberc Lung Dis 2009, 13:480-485.
26. Khader S.A., Rangel-moreno J., Jeffrey J., Martino C.A., Reiley W.W., John E., et al. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol 2009, 183.
27. Pitzalis C., Jones G.W., Bombardieri M., Jones S.A. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 2014, 14:447-462.
28. + T helper cells mediate protective immunity against tuberculosis. J Clin Invest 2013, 123:712-726.
29. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8:369-377.
30. Gopal R., Rangel-Moreno J., Slight S., Lin Y., Nawar H.F., Fallert Junecko B.A., et al. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol 2013, 6:972-984.
31. Sacks L.V., Pendel S. Factors related to in-hospital deaths in patients with tuberculosis. Arch Intern Med 1998, 158:1916-1922.
32. Berry M.P.R., Graham C.M., McNab F.W., Xu Z., Bloch S.A.A., Oni T., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
33. Eum S.-Y., Kong J.-H., Hong M.-S., Lee Y.-J. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 2010, 137:122-128.
34. Aly S., Wagner K., Keller C., Malm S., Malzan A., Brandau S., et al. Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice. J Pathol 2006, 210:298-305.
35. Keller C., Hoffmann R., Lang R., Brandau S., Hermann C., Ehlers S. Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun 2006, 74:4295-4309.
36. Kondratieva E., Logunova N., Majorov K., Averbakh M., Apt A. Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium. PLoS ONE 2010, 5.
37. Eruslanov E.B., Lyadova I.V., Tatiana K., Majorov K.B., Scheglov I.V., Orlova M.O., et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 2005, 73:1744-1753.
38. Dorhoi A., Iannaccone M., Farinacci M., Fae K.C., Schreiber J., Moura-Alves P., et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest 2013, 123:4836-4848.
39. Gopal R., Monin L., Torres D., Slight S.R., Mehra S., McKenna K., et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. Am J Respir Crit Care Med 2013, 188:1137-1146.
40. Anbarasu D., Raja C.P., Raja A. Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings. Cytokine 2013, 61:747-754.
41. Mihret A., Bekele Y., Bobosha K., Kidd M., Aseffa A., Howe R., et al. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection. J Infect 2013, 66:357-365.
42. Hilda J.N., Narasimhan M., Das S.D. Neutrophils from pulmonary tuberculosis patients show augmented levels of chemokines MIP-1alpha, IL-8 and MCP-1 which further increase upon in vitro infection with mycobacterial strains. Hum Immunol 2014, 75:914-922.
43. Flores-Villanueva P.O., Ruiz-Morales J.A., Song C.H., Flores L.M., Jo E.K., Montano M., et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005, 202:1649-1658.
44. Yu Y., Zhang Y., Hu S., Jin D., Chen X., Jin Q., et al. Different patterns of cytokines and chemokines combined with IFN-gamma production reflect Mycobacterium tuberculosis infection and disease. PLoS ONE 2012, 7:e44944.
45. Almeida Cde S., Abramo C., Alves C.C., Mazzoccoli L., Ferreira A.P., Teixeira H.C. Anti-mycobacterial treatment reduces high plasma levels of CXC-chemokines detected in active tuberculosis by cytometric bead array. Mem Inst Oswaldo Cruz 2009, 104:1039-1041.
46. Tang N.L., Fan H.P., Chang K.C., Ching J.K., Kong K.P., Yew W.W., et al. Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta: Int J Clin Chem 2009, 406:98-102.
47. Kaplan G., Post F.A., Moreira A.L., Wainwright H., Kreiswirth B.N., Tanverdi M., et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 2003, 71:7099-7108.
48. Ong C.W.M., Elkington P., Friedland J.S. Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am J Respir Crit Care Med 2014, 190:9-18.
49. Chan E.D., Chan J., Schluger N.W. What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am J Respir Cell Mol Biol 2001, 25:606-612.
50. Florido M., Cooper A.M., Appelberg R. Immunological basis of the development of necrotic lesions following Mycobacterium avium infection. Immunology 2002, 106:590-601.
51. Oddo M., Renno T., Attinger A., Bakker T., MacDonald H.R., Meylan P.R. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998, 160:5448-5454.
52. Riendeau C.J., Kornfeld H. THP-1 cell apoptosis in response to Mycobacterial infection. Infect Immun 2003, 71:254-259.
53. Volkman H.E., Pozos T.C., Zheng J., Davis J.M., Rawls J.F., Ramakrishnan L. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 2010, 327:466-469.
54. Elkington P., Shiomi T., Breen R., Nuttall R.K., Ugarte-Gil C.A., Walker N.F., et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 2011, 121:1827-1833.
55. Hernandez-Pando R., Orozco H., Arriaga K., Pavon L., Rook G. Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards type-2 in experimental pulmonary tuberculosis in Balb/c mice. Int J Exp Pathol 2000, 81:199-209.
56. Izzo A.A., Izzo L.S., Kasimos J., Majka S. A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection. Tuberculosis (Edinb) 2004, 84:387-396.
57. Taylor J.L., Hattle J.M., Dreitz S.A., Troudt J.M., Izzo L.S., Basaraba R.J., et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 2006, 74:6135-6144.
58. Lurie M.B. Experimental epidemiology of tuberculosis: the route of infection in naturally acquired tuberculosis of the guinea pig. J Exp Med 1930, 51:769-776.
59. Converse P.J., Dannenberg A.M., Estep J.E., Sugisaki K., Abe Y., Schofield B.H., et al. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect Immun 1996, 64:4776-4787.
60. Subbian S., Tsenova L., O'Brien P., Yang G., Koo M.S., Peixoto B., et al. Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. Am J Pathol 2011, 179:289-301.
61. Zhukova N.L., Gedymin L.E., Golyshevskaia V.I. Comparative characteristics of the activity of proteolytic enzymes and their inhibitors in the lung tissue of guinea pigs during development of generalized and destructive tuberculosis. Vop Med Khim 1986, 32:80-84.
62. Ugarte-Gil C.A., Elkington P., Gilman R.H., Coronel J., Tezera L.B., Bernabe-Ortiz A., et al. Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS ONE 2013, 8:e61333.
63. Van Lint P., Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007, 82:1375-1381.
64. McQuibban G.A., Butler G.S., Gong J.H., Bendall L., Power C., Clark-Lewis I., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001, 276:43503-43508.
65. Van Den Steen P.E., Proost P., Wuyts A., Van Damme J., Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000, 96:2673-2681.
66. Van Den Steen P.E., Husson S.J., Proost P., Van Damme J., Opdenakker G. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem Biophys Res Commun 2003, 310:889-896.
67. McQuibban G.A., Gong J.H., Wong J.P., Wallace J.L., Clark-Lewis I., Overall C.M. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100:1160-1167.
68. Van Den Steen P.E., Wuyts A., Husson S.J., Proost P., Van Damme J., Opdenakker G. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem/FEBS 2003, 270:3739-3749.
69. Li Q., Park P.W., Wilson C.L., Parks W.C. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002, 111:635-646.
70. Nolan A., Condos R., Huie M.L., Dawson R., Dheda K., Bateman E., et al. Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis. Int J Tuberc Lung Dis 2013, 17:922-927.
71. Pichugin A.V., Yan B.S., Sloutsky A., Kobzik L., Kramnik I. Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am J Pathol 2009, 174:2190-2201.
72. Carr M.W., Roth S.J., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 1994, 91:3652-3656.
73. Pokkali S., Das S.D. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Hum Immunol 2009, 70:110-115.
74. Xu L.L., Warren M.K., Rose W.L., Gong W., Wang J.M. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol 1996, 60:365-371.
75. Vesosky B., Rottinghaus E.K., Stromberg P., Turner J., Beamer G. CCL5 participates in early protection against Mycobacterium tuberculosis. J Leukoc Biol 2010, 87:1153-1165.
76. Freeman C.M., Stolberg V.R., Chiu B.C., Lukacs N.W., Kunkel S.L., Chensue S.W. CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schistosomal) anamnestic pulmonary granulomatous responses. J Immunol 2006, 177:4149-4158.
77. Telenti A. Safety concerns about CCR5 as an antiviral target. Curr Opin HIV AIDS 2009, 4:131-135.
78. Stolberg V.R., Chiu B.C., Martin B.E., Shah S.A., Sandor M., Chensue S.W. Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection. J Innate Immun 2011, 3:99-108.
79. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007, 8:639-646.
80. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 1999, 286:2098-2102.
81. + CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther 2006, 112:139-149.
82. Goncalves A.S., Appelberg R. The involvement of the chemokine receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in Mycobacterium avium infection. Scand J Immunol 2002, 55:585-591.